2016-03-08T00:00:00.000-05:00
lead product candidate,-0.56259
bio-manufacturing services,0.315317
consensus estimates,0.379168
earnings results,-0.244428
clinical trials,-0.480126
Analyst Ratings.Net reports,-0.256007
separate clinical trials,-0.56259
consensus price target,0.47016
subsidiary Avid Bioservices,0.42942
related companies,0.552682
InvestorPlace Broker Center,0.555736
brain cancer therapy,-0.585822
high fees,-0.735674
biopharmaceutical company,-0.397662
in-house manufacturing capabilities,0.42942
Peregrine Pharmaceuticals Daily,0.355687
Zacks Investment Research,0.40995
personal trading style,0.598412
PPHM,-0.213041
research offerings,0.40995
candidate bavituximab,-0.56259
average price,0.247019
HCV infection,-0.56259
concise daily summary,0.494163
stock broker,0.245696
mid-day trading,-0.371819
consensus rating,0.455862
recent Form,0.307854
Peregrine Pharmaceuticals,0.454185
